Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 5 (2009), Issue 2 (February)

1. Quantitative tests of liver function measure hepatic improvement after sustained virological response: results from the HALT-C trial.
   Aliment Pharmacol Ther, 29(5): 589-601. [Abstract] [Full-text]
2. Multidrug-experienced HIV-1-infected women demonstrated similar virological and immunological responses to tipranavir/ritonavir compared with men.
   AIDS, 23(3): 429-31. [Abstract] [Full-text]
3. Development of hepatocellular carcinoma in a patient 13 years after sustained virological response to interferon against chronic hepatitis C: a case report.
   Cases J, 2(1): 18. [Abstract] [Full-text]
4. On-treatment monitoring of adefovir therapy in chronic hepatitis B: virologic response can be assessed at 24 weeks.
   J Viral Hepat, 16(2): 113-20. [Abstract] [Full-text]
5. Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey.
   Liver Int, 29(2): 227-30. [Abstract] [Full-text]
6. Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study.
   Liver Int, 29(2): 248-52. [Abstract] [Full-text]
7. HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.
   J Viral Hepat, 16(1): 21-7. [Abstract] [Full-text]
8. Abbott RealTime hepatitis C virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV assays for prediction of sustained virological response to pegylated interferon and ribavirin in chronic hepatitis C patients.
   J Clin Microbiol, 47(2): 385-9. [Abstract] [Full-text]
9. Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes.
   J Infect Dis. [Abstract] [Full-text]
10. Virological and antigenic characterization of two Peste des Petits Ruminants (PPR) vaccine viruses of Indian origin.
    Comp Immunol Microbiol Infect Dis. [Abstract] [Full-text]
11. Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting.
    HIV Med, 10(2): 88-93. [Abstract] [Full-text]
12. Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
    J Antimicrob Chemother, 63(3): 585-92. [Abstract] [Full-text]
13. Hepatocellular carcinoma after sustained virologic response in hepatitis C patients without cirrhosis on a pretreatment liver biopsy.
    Eur J Gastroenterol Hepatol, 21(2): 225-9. [Abstract] [Full-text]
14. Virological Response and Hepatocarcinogenesis in Lamivudine-Resistant Hepatitis B Virus Genotype C Patients Treated with Lamivudine plus Adefovir Dipivoxil.
    Intervirology, 51(6): 385-393. [Abstract] [Full-text]
15. Virologic failure in therapy-naive subjects on aplaviroc plus lopinavir-ritonavir: detection of aplaviroc resistance requires clonal analysis of envelope.
    Antimicrob Agents Chemother, 53(3): 1124-31. [Abstract] [Full-text]
16. Virologic failure in first-line human immunodeficiency virus therapy with a CCR5 entry inhibitor, aplaviroc, plus a fixed-dose combination of lamivudine-zidovudine: nucleoside reverse transcriptase inhibitor resistance regardless of envelope tropism.
    Antimicrob Agents Chemother, 53(3): 1116-23. [Abstract] [Full-text]
17. Protease inhibitor levels in hair strongly predict virologic response to treatment.
    AIDS, 23(4): 471-8. [Abstract] [Full-text]
18. Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
    J Acquir Immune Defic Syndr, 50(3): 250-8. [Abstract] [Full-text]
19. Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda.
    J Acquir Immune Defic Syndr, 50(3): 276-82. [Abstract] [Full-text]
20. Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.
    Gastroenterology, 136(3): 856-62. [Abstract] [Full-text]
21. Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C with High Viral Load of Serum Hepatitis C Virus RNA, Genotype 1b, Discontinued on Attaining Sustained Virological Response at Week 16 after Onset of Acute Pancreatitis.
    Digestion, 79(1): 36-39. [Abstract] [Full-text]
22. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
    HIV Med, 10(3): 152-6. [Abstract] [Full-text]

© 2005-2010 Virology Research Today. All Rights Reserved.